Conclusion: α-2 Agonist monotherapy and, possibly to a lesser extent, co-treatment, are significantly superior to placebo for overall, hyperactivity, and inattentive ADHD symptoms. Efficacy advantages need to be balanced against fatigue, somnolence/sedation, hypotension, bradycardia, and possibly QTc prolongation.
PubMed 24472251 ↗Guanfacine Xr
People mainly take Guanfacine Xr for focus. Based on 3 first-hand reports and 1 meta-analyses & systematic reviews in the medical literature. Ranked #2015 of 3,539 overall.
Of reports that state an outcome, 50% are positive.
What Guanfacine Xr does, according to users
Of the people who reported each effect, the share who said it got better.
What the research says
Systematic reviews and meta-analyses from PubMed, with their published conclusions.
At least one meta-analysis, or 5+ randomized controlled trials. The grade measures how much human research exists — read the conclusions below for what it found.
Dosage people report
As stated by users — not a recommendation. Follow the label or your doctor.
Reported side effects
How often each side effect came up across all reports.
What users say
First-hand experiences, quoted verbatim. We show one positive and one negative where both exist.
“guanfacine XR (at higher than regular doses) have ever given me effects that I'd consider useful”
Other options for focus
User data from public discussions; research from PubMed. Information only, not medical advice — talk to a doctor before starting, stopping or combining anything. Data updated October 3, 2026. How we rate